Non-Accredited Satellite Symposia

Improving Patient Safety with Multi-modal Noninvasive Monitoring

Presented by Masimo, ASA Industry Supporter

Saturday, October 21 | Noon - 1 p.m.
Boston Convention & Exhibition Center, Room 206 AB, Level 2


Donald Mathews, M.D.
Chair of the Department of Anesthesiology,
Health Care Service Chief of Anesthesiology
Professor of Anesthesiology, University of Vermont, Burlington

Aryeh Shander, M.D., FCCM, FCCP
Chief of Anesthesiology, Critical Care Medicine,
Pain Management, and Hyperbaric Medicine
Executive Medical Director of the Institute for Patient Blood Management and Bloodless Medicine and Surgery
Clinical Research Director for TEAMHealth Anesthesia, Englewood Hospital and Medical Center

Michael Ramsay, M.D.
Chairman of the Department of Anesthesiology and Pain Management
President of Baylor Research Institute, Baylor University Medical Center

This symposium will discuss recent advancements in noninvasive clinical monitoring, such as noninvasive and continuous hemoglobin, pleth variability index, and brain function monitoring, when used together, may help provide additional clinical insights towards patient safety.  Register here or see a Masimo representative in Booth # 1626.

Why is My Patient Hypotensive and Does it Matter?

Presented by Edwards Lifesciences, ASA Industry Supporter

Saturday, October 21 | Noon - 1 p.m.
Boston Convention & Exhibition Center, Room 210C, Level 2


Monty Mythen, M.B., B.S., M.D. 
Daniel Sessler, M.D. 
Manuel Ignacio Monge Garcia, M.D.

This symposium will discuss how emerging literature is demonstrating that periods of hypotension in the surgical setting are common and are associated with patient risk.  Further, significant differences exist in the choice and interpretation of monitoring techniques among anesthesiologists.  This program will review clinical evidence describing the risk of intraoperative hypotension (IOH) and discuss the concepts of pressure and flow to guide clinical decision making.  Register here or see an Edwards representative in Booth # 3111.

Infectious Disease Transmission in the Operating Room:  Clinical Research Illuminates the Risk

Presented by B. Braun Medical, Inc.

Sunday, October 22 | 5:30 a.m. - Breakfast,  6 - 8 a.m. - Program
Renaissance Boston Waterfront Hotel, Pacific Ballroom Salons A-E


Randy Loftus, M.D.
Associate Professor, Anesthesiology

This symposium will review the overall magnitude and implications of intravascular device contamination events, and describe innovative technology for continually tracking device contamination in order to optimize provider compliance.  To register, visit

A Potential New Path to Pain Relief:  Multimodal Analgesia for Enhanced Recovery with a Peripherally Acting Kappa Opioid Receptor Agonist (KORA)

Presented by Cara Therapeutics, ASA Annual Meeting Supporter

Sunday, October 22 | 6:30 a.m. - Breakfast, 7 - 8 a.m. - Program
Westin Boston Waterfront Hotel, Harbor Ballroom 1 and 2, Conference Level


Joseph W. Stauffer, D.O., M.B.A.
Chief Medical Officer, Cara Therapeutics, Inc.

Christopher L. Wu, M.D.
Professor, Division of Obstetric Anesthesiology
Division of Regional Anesthesia and Acute Pain Medicine
Department of Anesthesiology, The Johns Hopkins Hospital

This symposium will describe how traditional mu opioid agonists play an important role in postoperative analgesia.  However, their use is associated with adverse effects such as respiratory depression, nausea and vomiting, which can delay postoperative recovery and increase health care costs.  In addition, mu opioid analgesics are responsible for morbidity and mortality due to the public health epidemics of abuse and overdose.  A novel peripherally acting kappa opioid receptor agonist (KORA), CR845, is currently in Phase 3 trials for postoperative pain (IV CR845) and Phase 2 trials for chronic pain (oral CR845).  Because of its unique pharmacologic properties, CR845 has been shown to produce analgesia with little-to-no traditional mu opioid side effects and low abuse potential.  During this satellite symposium, the faculty will discuss analgesic drugs and techniques currently used in enhanced recovery after surgery (ERAS) protocols - an evolving paradigm for multimodal perioperative care, review the clinical data for CR845, and consider CR845's potential place in postoperative analgesia.  Register now.     

Opioid Medication Safety Issues:  The Need for Anesthesiologist Engagement

Presented by Fresenius Kabi, ASA Industry Supporter

Sunday, October 22 | Noon - 1 p.m.
Westin Boston Waterfront Hotel, Harbor Ballroom 1 and 2


Eugene R. Viscusi, M.D.
Professor of Anesthesiology, Chief of Pain Medicine
Director, Acute Pain Management, Dept. of Anesthesiology
Sidney Kimmel Medical College at Thomas Jefferson University

Matthew Grissinger, RPh, FISMP, FASHP
Director, Error Reporting Programs, ISMP

Ronald S. Litman, D.O.
Pediatric Anesthesiologist, Children's Hospital of Philadelphia
Professor of Anesthesiology and Pediatrics
Perelman School of Medicine, University of Pennsylvania
Medical Director, ISMP

This symposium will educate the anesthesia community about the continued opioid medication safety challenges and discuss anesthesia's leadership role in error prevention. To register, see a Fresenius Kabi representative in Booth #1617 or Register now. 

Fresenius Kabi recognizes the Institute for Safe Medication Practices (ISMP) for their significant contributions to the development of this program.

Clinical Considerations in Neuromuscular Blockade Management

Presented by Merck, ASA Industry Supporter

Sunday, October 22 | Noon - 1 p.m.
Boston Convention & Exhibition Center, Ballroom East


Peter Schoenwald, M.D. 
Associate Professor of Anesthesiology 
Cleveland Clinic Lerner College of Medicine

This symposium will discuss clinical rationale and society guidelines related to neuromuscular monitoring.  It will also include clinical data for an FDA approved agent that reverses moderate and deep neuromuscular blockade.  No registration is necessary.

Disclaimer:  "Merck is pleased to sponsor this program to provide information consistent with FDA guidelines.  This program is not an accredited CME program and is not designed to meet any training and/or educational requirements.  This medical education program is for U.S. health care professionals and health care business professionals only.  The speaker for this program is speaking on behalf of Merck."

Advancements in Enhanced Recovery After Surgery (ERAS) Initiatives

Presented by Smiths Medical

Sunday, October 22 | 7 - 9 p.m. 
Westin Boston Waterfront Hotel, Harbor Ballroom 1 and 2


Monty Mythen, M.B.B.S., M.D., FRCA, FFICM, FCAI (Hon)
University College London, London, UK

Anoushka Afonso, M.D.
Memorial Sloan Kettering Cancer Center, NY

Tim Miller, M.B., Ch.B., FRCA
Duke University, NC

Mike Grocott, M.D., FRCP, FRCA, FFICM
University of Southampton, Southampton, UK

This symposium will feature a panel discussion and lectures focused on advancing surgical patient care through Enhanced Recovery After Surgery (ERAS) protocols.  During this session, we will discuss the benefits and challenges of implementing an ERAS program into your surgical care, evidence-based therapy recommendations from the American Society of Enhanced Recovery's Perioperative Quality Initiatives consensus statements, techniques and benefits of optimizing analgesia throughout the perioperative setting and case discussions highlighting the implementation and key therapies of ERAS.  Register here or see a Smiths Medical representative in Booth # 2417.

Pharmacokinetics and Dynamics of Sublingual Sufentanil

Presented by AcelRx Pharmaceuticals, Inc.

Monday, October 23 | 6:30 - 8 a.m. 
Westin Boston Waterfront Hotel, Grand Ballroom B-E


Eugene R. Viscusi, M.D.
Thomas Jefferson University Hospital

Albert Dahan, M.D., Ph.D.
Leiden University Medical Center

Dennis Fisher, M.D.
P Less Than Corporation and the University of California San Francisco

This symposium will discuss the pharmacokinetics and dynamics of sublingual sufentanil and a comparison to IV opioid administration.  You may register one of three ways:  online, at the door, or see an AcelRx Pharmaceuticals representative in Booth # 1435.   

Standardize 4 Safety:  Concentrating on Concentrations

Presented by PharMEDium Services, LLC, ASA Industry Supporter

Monday, October 23 | Noon - 1 p.m.
Boston Convention & Exhibition Center, Ballroom West


Deborah A. Pasko, Pharm.D., M.H.A.
Director of Medication Safety & Quality, ASHP

This symposium will review how a national effort to standardize medication concentrations is helping to reduce errors and improve transitions of care, and describe how the Standardize 4 Safety initiative is creating, testing, publicizing, and supporting the adoption of national standardized medication concentrations.  Register online or see a PharMEDium representative in Booth # 2817.

Meeting Quality Demands in a Competitive Marketplace

Presented by ePreop, ASA Industry Supporter

Monday, October 23 | Noon - 1 p.m. 
Boston Convention & Exhibition Center, Ballroom East


David Bergman, D.O.
CEO, ePreop

Eric Hansen, M.D.
Director of Clinical Quality, Oregon Anesthesiology Group

Brian Woods, M.D.
VP, Chief Medical Officer, NorthStar Anesthesia

This symposium will explain how to meet CMS reporting requirements while building a full Quality Improvement program.  The focus will be on how to help you compete in a changing marketplace, support stipends, and fulfill contract requirements.  Register here or see a ePreop representative in Booth # 2635.





Helpful Information

Last chance! Early-bird savings end July 24.


Register now  arrow


ASA Membership Matters

ASA members receive deep discounts on registration. Join today!


Thank You Industry Supporters

Whose contributions allow the American Society of Anesthesiologists® to create world-class education and resources to improve patient care and outcomes.


ASA Industry Supporters



Thank You Annual Meeting Supporters


ASA Industry Supporters